Osaic Holdings’s Tema Oncology ETF CANC Stock Holding History
Bought
Maintained
Sold
Other funds holding CANC
Osaic Holdings's CANC Position: Q3 2026 in Review
Osaic Holdings increased its Tema Oncology ETF (CANC) stake by 27% in Q3 2026, buying an estimated $4.23K and bringing the position to 470 shares worth $19.7K. The position accounts for ﹤0.01% of the portfolio, ranked #6207.
Osaic Holdings first reported a position in CANC in Q4 2023 and has held it in 11 quarters since. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.
- Osaic Holdings held 470 shares of Tema Oncology ETF worth $19.7K as of Q3 2026.
- Osaic Holdings bought 100 Tema Oncology ETF shares in Q3 2026, an estimated $4.23K.
- Tema Oncology ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #6207 holding.
- Osaic Holdings first reported a position in Tema Oncology ETF in Q4 2023 and has held it in 11 quarters since.
- 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.
Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.